BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32030506)

  • 1. Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.
    Crinò A; Grugni G
    Curr Diab Rep; 2020 Feb; 20(2):7. PubMed ID: 32030506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome.
    Krochik AG; Ozuna B; Torrado M; Chertkoff L; Mazza C
    J Pediatr Endocrinol Metab; 2006 Jul; 19(7):911-8. PubMed ID: 16995571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.
    Zipf WB
    Acta Paediatr Suppl; 1999 Dec; 88(433):115-7. PubMed ID: 10626560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
    L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
    Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do patients with Prader-Willi syndrome have favorable glucose metabolism?
    Qian Y; Xia F; Zuo Y; Zhong M; Yang L; Jiang Y; Zou C
    Orphanet J Rare Dis; 2022 May; 17(1):187. PubMed ID: 35525976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.
    Schuster DP; Osei K; Zipf WB
    Metabolism; 1996 Dec; 45(12):1514-20. PubMed ID: 8969285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
    Yang A; Kim J; Cho SY; Jin DK
    Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
    Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
    Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity.
    Lacroix D; Moutel S; Coupaye M; Huvenne H; Faucher P; Pelloux V; Rouault C; Bastard JP; Cagnard N; Dubern B; Clément K; Poitou C
    J Clin Endocrinol Metab; 2015 Mar; 100(3):850-9. PubMed ID: 25478934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prader Willi syndrome: endocrine updates and new medical therapies.
    Harris RM; Stafford DEJ
    Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):56-62. PubMed ID: 31815782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity.
    Höybye C; Hilding A; Jacobsson H; Thorén M
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3590-7. PubMed ID: 12161480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
    Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
    Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
    Talebizadeh Z; Butler MG
    Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
    Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
    J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prader-Willi syndrome: endocrine manifestations and management.
    Alves C; Franco RR
    Arch Endocrinol Metab; 2020; 64(3):223-234. PubMed ID: 32555988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of obesity in Prader-Willi syndrome.
    Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
    Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.